Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes
Belinda Schludi, Abu Saleh Md Moin, Chiara Montemurro, Tatyana Gurlo, Aleksey V. Matveyenko, David Kirakossian, David W. Dawson, Sarah M. Dry, Peter C. Butler, Alexandra E. Butler
Belinda Schludi, Abu Saleh Md Moin, Chiara Montemurro, Tatyana Gurlo, Aleksey V. Matveyenko, David Kirakossian, David W. Dawson, Sarah M. Dry, Peter C. Butler, Alexandra E. Butler
View: Text | PDF
Research Article Endocrinology

Islet inflammation and ductal proliferation may be linked to increased pancreatitis risk in type 2 diabetes

  • Text
  • PDF
Abstract

Pancreatitis is more frequent in type 2 diabetes mellitus (T2DM), although the underlying cause is unknown. We tested the hypothesis that ongoing β cell stress and apoptosis in T2DM induces ductal tree proliferation, particularly the pancreatic duct gland (PDG) compartment, and thus potentially obstructs exocrine outflow, a well-established cause of pancreatitis. PDG replication was increased 2-fold in human pancreas from individuals with T2DM, and was associated with increased pancreatic intraepithelial neoplasia (PanIN), lesions associated with pancreatic inflammation and with the potential to obstruct pancreatic outflow. Increased PDG replication in the prediabetic human-IAPP-transgenic (HIP) rat model of T2DM was concordant with increased β cell stress but preceded metabolic derangement. Moreover, the most abundantly expressed chemokines released by the islets in response to β cell stress in T2DM, CXCL1, -4, and -10, induced proliferation in human pancreatic ductal epithelium. Also, the diabetes medications reported as potential modifiers for the risk of pancreatitis in T2DM modulated PDG proliferation accordingly. We conclude that chronic stimulation and proliferation of the PDG compartment in response to islet inflammation in T2DM is a potentially novel mechanism that serves as a link to the increased risk for pancreatitis in T2DM and may potentially be modified by currently available diabetes therapy.

Authors

Belinda Schludi, Abu Saleh Md Moin, Chiara Montemurro, Tatyana Gurlo, Aleksey V. Matveyenko, David Kirakossian, David W. Dawson, Sarah M. Dry, Peter C. Butler, Alexandra E. Butler

×

Figure 2

Pancreatic duct glands (PDGs) are present throughout the human pancreas with increased PDG cell replication in type 2 diabetes mellitus (T2DM).

Options: View larger image (or click on image) Download as PowerPoint
Pancreatic duct glands (PDGs) are present throughout the human pancreas ...
(A and B) Examples of PDGs (arrows) in cross section in mesenchyme surrounding pancreatic ducts (A and B: donor 6015). PDGs and interlobular duct epithelium (but not intralobular pancreatic ducts) stain positively for mucin (Alcian blue) and are continuous and open into the interlobular duct epithelium (arrowheads); Stars indicate interlobular duct lumen; pink arrow indicates insulin-positive cell in PDG epithelium. Scale bars: 50 μm. (C and D) Representative examples of the PDG compartment in a nondiabetic (ND) subject (C: donor 6165) and a subject with T2DM (D: donor 6133) stained for Ki67 (brown) and with Alcian blue. Scale bars: 50 μm. Stars indicate interlobular duct lumen; black arrows indicate Ki67-positive nuclei in the PDG epithelium. Scale bars: 50 μm. (E) PDGs in human pancreas are present in the head, body, and tail with a comparable abundance in individuals with T2DM and ND controls (head: 9.9 ± 2.8 vs. 9.4 ± 2.8 PDGs/mm2 pancreas, T2DM [n = 14] vs. ND [n = 13], P = ns; body: 8.1 ± 2.1 vs. 9.6 ± 2.8 PDGs/mm2 pancreas, T2DM [n = 14] vs. ND [n = 7], P = ns; tail: 5.7 ± 1.6 vs. 6.1 ± 1.2 PDGs/mm2 pancreas, T2DM [n = 14] vs. ND [n = 13], P = ns). Open circles = ND donors, black squares= T2DM donors. (F) The frequency of PDG cell replication and interlobular pancreatic duct replication is increased in T2DM compared with ND controls (PDG: 2.0% ± 0.4% vs. 0.8% ± 0.1%, T2DM [n = 42] vs. ND [n = 33], **P < 0.01; interlobular duct: 2.0% ± 0.4% vs. 0.8% ± 0.1%, T2DM [n = 42] vs. ND [n = 33]). **P < 0.01. Open circles = ND donors, black squares = T2DM donors. Data represent mean ± SEM; 1-tailed Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts